Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa

C. Finelli, L. Gugliotta, B. Gamberi, N. Vianelli, G. Visani, S. Tura

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Following reports that recombinant interferon alfa (rIFNα), besides inducing clinical and hematologic remission in polycythemia vera (PV), can also resolve intractable pruritus, we used rIFNα to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and/or cytostatics). rIFNα was administered intramuscularly three times a week at a dosage of 3.0 x 106 U. Eight patients (61.5%) reported a ≥50% reduction of pruritus, which occurred within 2-8 weeks from the start of rIFNα treatment, leading to a substantial improvement in their quality of life. Three patients had to stop rIFNα within the first month of therapy because of unacceptable side effects. Thus rIFNα seems to be capable of providing considerable relief of otherwise intractable pruritus in a good proportion of PV patients.

Original languageEnglish
Pages (from-to)316-318
Number of pages3
JournalAmerican Journal of Hematology
Volume43
Issue number4
Publication statusPublished - 1993

Fingerprint

Polycythemia Vera
Pruritus
Interferon-alpha
Phlebotomy
Cytostatic Agents
Therapeutics
Quality of Life

Keywords

  • polycythemia vera (PV)
  • pruritus
  • recombinant interferon alfa (rIFNα)

ASJC Scopus subject areas

  • Hematology

Cite this

Finelli, C., Gugliotta, L., Gamberi, B., Vianelli, N., Visani, G., & Tura, S. (1993). Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa. American Journal of Hematology, 43(4), 316-318.

Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa. / Finelli, C.; Gugliotta, L.; Gamberi, B.; Vianelli, N.; Visani, G.; Tura, S.

In: American Journal of Hematology, Vol. 43, No. 4, 1993, p. 316-318.

Research output: Contribution to journalArticle

Finelli, C, Gugliotta, L, Gamberi, B, Vianelli, N, Visani, G & Tura, S 1993, 'Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa', American Journal of Hematology, vol. 43, no. 4, pp. 316-318.
Finelli, C. ; Gugliotta, L. ; Gamberi, B. ; Vianelli, N. ; Visani, G. ; Tura, S. / Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa. In: American Journal of Hematology. 1993 ; Vol. 43, No. 4. pp. 316-318.
@article{7ff5fc7c776c492e87d0d8b3aa0429d0,
title = "Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa",
abstract = "Following reports that recombinant interferon alfa (rIFNα), besides inducing clinical and hematologic remission in polycythemia vera (PV), can also resolve intractable pruritus, we used rIFNα to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and/or cytostatics). rIFNα was administered intramuscularly three times a week at a dosage of 3.0 x 106 U. Eight patients (61.5{\%}) reported a ≥50{\%} reduction of pruritus, which occurred within 2-8 weeks from the start of rIFNα treatment, leading to a substantial improvement in their quality of life. Three patients had to stop rIFNα within the first month of therapy because of unacceptable side effects. Thus rIFNα seems to be capable of providing considerable relief of otherwise intractable pruritus in a good proportion of PV patients.",
keywords = "polycythemia vera (PV), pruritus, recombinant interferon alfa (rIFNα)",
author = "C. Finelli and L. Gugliotta and B. Gamberi and N. Vianelli and G. Visani and S. Tura",
year = "1993",
language = "English",
volume = "43",
pages = "316--318",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - Relief of intractable pruritus in polycythemia vera with recombinant interferon alfa

AU - Finelli, C.

AU - Gugliotta, L.

AU - Gamberi, B.

AU - Vianelli, N.

AU - Visani, G.

AU - Tura, S.

PY - 1993

Y1 - 1993

N2 - Following reports that recombinant interferon alfa (rIFNα), besides inducing clinical and hematologic remission in polycythemia vera (PV), can also resolve intractable pruritus, we used rIFNα to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and/or cytostatics). rIFNα was administered intramuscularly three times a week at a dosage of 3.0 x 106 U. Eight patients (61.5%) reported a ≥50% reduction of pruritus, which occurred within 2-8 weeks from the start of rIFNα treatment, leading to a substantial improvement in their quality of life. Three patients had to stop rIFNα within the first month of therapy because of unacceptable side effects. Thus rIFNα seems to be capable of providing considerable relief of otherwise intractable pruritus in a good proportion of PV patients.

AB - Following reports that recombinant interferon alfa (rIFNα), besides inducing clinical and hematologic remission in polycythemia vera (PV), can also resolve intractable pruritus, we used rIFNα to treat 13 PV patients complaining of severe pruritus refractory to conventional treatment (venesection and/or cytostatics). rIFNα was administered intramuscularly three times a week at a dosage of 3.0 x 106 U. Eight patients (61.5%) reported a ≥50% reduction of pruritus, which occurred within 2-8 weeks from the start of rIFNα treatment, leading to a substantial improvement in their quality of life. Three patients had to stop rIFNα within the first month of therapy because of unacceptable side effects. Thus rIFNα seems to be capable of providing considerable relief of otherwise intractable pruritus in a good proportion of PV patients.

KW - polycythemia vera (PV)

KW - pruritus

KW - recombinant interferon alfa (rIFNα)

UR - http://www.scopus.com/inward/record.url?scp=0027254816&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027254816&partnerID=8YFLogxK

M3 - Article

C2 - 8372816

AN - SCOPUS:0027254816

VL - 43

SP - 316

EP - 318

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 4

ER -